Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group

Archivio Italiano di Urologia e Andrologia

Volumn 87, Issue 2, 2015, Pages 105-120

  Prezioso, Domenico ^a   Strazzullo, Pasquale ^a   Lotti, Tullio ^a   Bianchi, Giampaolo ^b   Borghi, Loris ^c   Caione, Paolo ^d   Carini, Marco ^e   Caudarella, Renata ^f   Ferraro, Pietro Manuel ^g   Gambaro, Giovanni ^g   Gelosa, Marco ^h   Guttilla, Andrea ⁱ   Illiano, Ester ^a   Martino, Marangella ^j   Meschi, Tiziana ^c   Messa, Piergiorgio ^h   Miano, Roberto ^h,k   Napodano, Giorgio ^l   Nouvenne, Antonio ^c   Rendina, Domenico ^a   Rocco, Francesco ^h   Rosa, Marco ^b   Sanseverino, Roberto ^l   Salerno, Annamaria ^m   Spatafora, Sebastiano ⁿ   Tasca, Andrea ^o   Ticinesi, Andrea ^c   Travaglini, Fabrizio ^e   Trinchieri, Alberto ^p   Vespasiani, Giuseppe ^h,k   Zattoni, Filiberto ⁱ   more..

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^e Azienda Ospedaliero Universitaria di Careggi   (Italy)

^f Casa di Cura Villalba ^*  (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

^h FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

ⁱ UNIVERSITY OF PADOVA   (Italy)

^j MAURIZIANO HOSPITAL   (Italy)

^k UNIVERSITY OF ROME TOR VERGATA   (Italy)

^l Ospedale Umberto I   (Italy)

^m UNIVERSITY CAMPUS BIO MEDICO   (Italy)

ⁿ S MARIA NUOVA HOSPITAL   (Italy)

^o Ospedale San Bartolo di Vicenza   (Italy)

^p A MANZONI HOSPITAL   (Italy)

more..

Author keywords

Children; Dietary treatment; Elderly; Hypercalciuria; Hyperoxaluria; Hypocitraturia; Urinary calculi; Urinary risk factors

Indexed keywords

BONE MASS; CALCIUM INTAKE; CALCIUM URINE LEVEL; CONSERVATIVE TREATMENT; DIET SUPPLEMENTATION; DIET THERAPY; FLUID INTAKE; HUMAN; HYPERCALCIURIA; HYPEROXALURIA; HYPERURICOSURIA; HYPOCITRATURIA; META ANALYSIS; NEPHROLITHIASIS; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PROTEIN INTAKE; REVIEW; RISK FACTOR; RISK REDUCTION; SODIUM RESTRICTION; SYSTEMATIC REVIEW; URINARY EXCRETION; ADMINISTRATION AND DOSAGE; ADULT; AGED; CHILD; EVIDENCE BASED MEDICINE; KIDNEY CALCULI; MEDICAL SOCIETY; METABOLISM; NEPHROLOGY; PATIENT EDUCATION; PRACTICE GUIDELINE; SODIUM INTAKE; TREATMENT OUTCOME; URINE;

CALCIUM INTAKE; CALCIUM OXALATE; CITRIC ACID; DRINKING WATER; PROTEIN INTAKE; SODIUM INTAKE;

ADULT; AGED; CALCIUM OXALATE; CALCIUM, DIETARY; CHILD; CITRIC ACID; DIETARY PROTEINS; DIETARY SUPPLEMENTS; DRINKING WATER; EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY CALCULI; NEPHROLOGY; PATIENT EDUCATION AS TOPIC; RISK FACTORS; SOCIETIES, MEDICAL; SODIUM, DIETARY; TREATMENT OUTCOME;

EID: 84946010548     PISSN: 11243562     EISSN: 22824197     Source Type: Journal    
DOI: 10.4081/aiua.2015.2.105     Document Type: Review

References (203)

1. Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010; 12:86-96.
2. Sakhaee K, Maalouf NM, Sinnott B. Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management. J Clin Endocrinol Metab. 2012; 97:1847-1860.
3. Worcester EM, Coe FL. Clinical practice. Calcium kidney stones. N Engl J Med. 2010; 363:954-963.
4. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 2005; 115:2598-2608.
5. Lotan Y. Economics and cost of care of stone disease. Adv Chronic Kidney Dis. 2009; 16:5-10.
6. Shoag J, Halpern J, Goldfarb DS, Eisner BH. Risk of chronic and end stage kidney disease in patients with nephrolithiasis. J Urol. 2014; 192:1440-5.
7. Worcester EM, Coe FL. Nephrolithiasis. Prim Care 2008; 35:369-391.
8. Turney B W, Appleby PN, Reynard JM, Net al. Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Epidemiol. 2014; 29:363-9.
9. Rendina D, De Filippo G, De Pascale F, et al. The changing profile of patients with calcium nephrolithiasis and the ascendancy of overweight and obesity: a comparison of two patient series observed 25 years apart. Nephrol Dial Transplant. 2013; 28 Suppl 4:iv146-51.
10. Rendina D, De Filippo G, D'Elia L, Strazzullo P. Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence. J Nephrol. 2014 Apr 3.
11. Wiederkehr MR, Moe O W. Uric Acid Nephrolithiasis: A Systemic Metabolic Disorder. Clin Rev Bone Miner Metab. 2011; 9:207-217.
12. Cupisti A. Update on nephrolithiasis: beyond symptomatic urinary tract obstruction. J Nephrol. 2011; 24 Suppl 18:S25-9.
13. Sakhaee K. Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens. 2008; 17:304-9.
14. Percorso diagnostico-terapeutico per il paziente con calcolosi uri-naria. Gruppo di Studio Multidisciplinare per la Calcolosi Renale. Giornale Italiano di Nefrologia 2010; 27:282-289.
15. Pearle MS, Goldfarb DS, Assimos DG, et al. American Urological Assocation. Medical management of kidney stones: AUA guideline. J Urol. 2014; 192:316-24.
16. Pak CY, Heller HJ, Pearle MS, et al. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. J Urol. 2003; 169:465-9.
17. Kourambas J, Aslan P, Teh CL, et al. Role of stone analysis in metabolic evaluation and medical treatment of nephrolithiasis. Endourol. 2001; 15: 181-6.
18. Ramakumar S, Patterson DE, LeRoy AJ, et al: Prediction of stone composition from plain radiographs: a prospective study. J Endourol 1999; 13:397-401.
19. Mandel N, Mandel I, Fryjoff K, et al. Conversion of calcium oxalate to calcium phosphate with recurrent stone episodes. J Urol. 2003; 169:2026-9.
20. Badereddin Mohamad Al-Ali, Johanna Patzak, Herbert Augustin. Impact of urinary stone volume on computed tomography stone attenuations measured in Hounsfield units in a large group of Austrian patients with urolithiasis. Cent European J Urol. 2014; 67:289-95.
21. Hesse A, Kruse R, Geilenkeuser WJ, et al. Quality control in urinary stone analysis: results of 44 ring trials (1980-2001). Clin Chem Lab Med. 2005; 43:298-303.
22. Suror DJ, Scheidt S. Identification standards for human urinary calculus components, using crystallographic methods. Br J Urol. 1968; 40:22-8.
23. Abdel-Halim RE, Abdel-Halim MR. A review of urinary stone analysis techniques. Saudi Med J. 2006; 27:1462-7.
24. Kasidas G P, Samuell CT, Weir TB. Renal stone analysis: why and how? Ann.Clin.Biochem. 2004; 41:91-7.
25. Douglas DE, Tonks DB. The qualitative analysis of renal calculi with the polarising microscope. Clin Biochem. 1979; 12:182-3.
26. Abbas Basiri, Maryam Taheri, FatemehTaheri.What is the State of the Stone Analysis Techniques in Urolithiasis? Urology Journal 2012; 9:445-454.
27. Hidas G, Eliahou R, Duvdevani M, et al. Determination of renal stone composition with dual-energy CT: in vivo analysis and comparison with X-ray diffraction. Radiology. 2010; 257:394-401.
28. Borghi L, Meschi T, Schianchi T, et al: Urine volume: Stone risk factor and preventive measure. Nephron 1999; 81(suppl 1):31-37.
29. Pak CYC, Sakhaee K, Crowther C & Brinkley L. Evidence justifying a high fluid intake in treatment of nephrolithiasis. Ann. Intern. Med. 1980; 93:36-39.
30. Borghi L, Meschi T, Amato F, et al: Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996; 155:839.
31. Sarica K, Inal Y, Erturhan S, Yagci F. The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy. Urol Res. 2006; 34:184-9.
32. Frank M, De Vries A, Tikva P. Prevention of urolithiasis.Education to adequate fluid intake in a new town situated in the Judean Desert Mountains. Archives of Environmental Health. 1966; 13:625-30.
33. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. New England Journal of Medicine 1993; 328:833-8.
34. Coen G, Sardella D, Barbera G, et al. Urinary composition and lithogenic risk in normal subjects following oligomineral versus bicarbonate-alkaline high calcium mineral water intake. Urol Int. 2001; 67:49-53.
35. Gutenbrunner C, Gilsdorf K, Hildebrandt G. The effect of mineral water containing calcium on supersaturation of urine with calcium oxalate. Urologe A. 1989; 28:15-19.
36. Rodgers AL. The influence of South African mineral water on reduction of risk of calcium oxalate kidney stone formation. S Afr Med J. 1998; 88:448-451.
37. Trinchieri A, Boccafoschi C, Chisena S, et al. Study of the diuretic efficacy and tolerability of therapy with Rocchetta mineral water in patients with recurrent calcium kidney stones. Arch Ital Urol Androl. 1999; 71:121-124.
38. Karagülle O, Smorag U, Candir F, et al. Clinical study on the eVect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithia-sis World J Urol. 2007; 25:315-323.
39. Bertaccini A, Borghesi M. Indications for a medium mineral high bicarbonate water (Cerelia) in urology. Arch Ital Urol Androl. 2009; 81:192-4.
40. Siener R, Jahnen A, Hesse A Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization. European Journal of Clinical Nutrition. 2004; 58, 270-276.
41. Escribano J, Balaguer A, Roqué i Figuls M, et al. Dietary interventions for preventing complications in idiopathic hypercalciuria. The Cochrane Library 2014, Issue 2.
42. Nishiura JL, Campos AH, Boim MA, et al. Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients. Urological Research 2004; 32:362-6.
43. Coe FL, Parks JH, Webb DR. Stone-forming potential of milk or calcium-fortified orange juice in idiopathic hypercalciuric adults. Kidney International 1992; 41: 139-42.
44. Taylor EN, Curhan GC. Demographic, dietary, and urinary factors and 24-h urinary calcium excretion. Clin J Am Soc Nephrol. 2009; 4:1980-7.
45. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993; 328:833-8.
46. Pak CY, Odvina C V, Pearle MS, et al. Effect of dietary modification on urinary stone risk factors. Kidney Int. 2005; 68:2264-73.
47. Damasio B, Massarino F, Durand F, et al. Prevalence of fasting hypercalciuria associated with increased citraturia in the ambulatory evaluation of nephrolithiasis. J Nephrol. 2005; 18:262-6.
48. Burtis WJ, Gay L, Insogna KL, et al. Dietary hypercalciuria in patients with calcium oxalate kidney stones. Am J Clin Nutr. 1994; 60:424-9.
49. Jaeger P, Portmann L, Jacquet A F, Burckhardt P. Influence of the calcium content of the diet on the incidence of mild hyperoxaluria in idio-pathic renal stone formers. Am J Nephrol. 1985; 5:40-4.
50. Nishiura JL, Martini LA, Mendonça CO, et al. Effect of calcium intake on urinary oxalate excretion in calcium stone-forming patients. Braz J Med Biol Res. 2002; 35:669-75.
51. Heilberg I P, Martini LA, Draibe SA, et al. Sensitivity to calcium intake in calcium stone forming patients. Nephron. 1996; 73:145-53.
52. Nakada T, Sasagawa I, Furuta H, et al. Effect of high-calcium diet on urinary oxalate excretion in urinary stone formers. Eur Urol. 1988; 15:264-70.
53. van Faassen A, van der Ploeg EM, Habets HM, et al. The effects of the calcium-restricted diet of urolithiasis patients with absorptive hypercalciuria type II on risk factors for kidney stones and osteopenia. Urol Res. 1998; 26:65-9.
54. Messa P, Marangella M, Paganin L, et al. Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones. Clin Sci. 1997; 93:257-63.
55. Bataille P, Pruna A, Grégoire I, et al. Critical role of oxalate restriction in association with calcium restriction to decrease the probability of being a stone former: insufficient effect in idiopathic hyper-calciuria. Nephron. 1985; 39:321-4.
56. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002; 346:77-84.
57. Nouvenne A, Meschi T, Prati B, et al. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr. 2010; 91:565-70.
58. Giannini S, Nobile M, Sartori L, et al. Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr. 1999; 69:267-71.
59. Taylor EN, Stampfer MJ, Curhan GC. Fatty acid intake and incident nephrolithiasis. Am J Kidney Dis. 2005; 45:267-74.
60. Rothwell PJ, Green R, Blacklock NJ, Kavanagh J P. Does fish oil benefit stone formers? J Urol. 1993; 150:1391-4.
61. Ortiz-Alvarado O, Miyaoka R, Kriedberg C, et al. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid in the management of hypercalciuric stone formers. Urology. 2012; 79:282-6.
62. Yasui T, Tanaka H, Fujita K, et al. Effects of eicosapentaenoic acid on urinary calcium excretion in calcium stone formers. Eur Urol. 2001; 39:580-5.
63. Ohkawa T, Ebisuno S, Kitagawa M, et al. Rice bran treatment for patients with hypercalciuric stones: experimental and clinical studies. J Urol. 1984; 132:1140-5.
64. Strohmaier WL, Kalchthaler M, Bichler KH. Calcium metabolism in normal and in hypercalciuric patients on Farnolith, a dietary fibre preparation. Urol Res. 1988; 16:437-40.
65. Tizzani A, Casetta G, Piana P, Vercelli D. Wheat bran in the selective therapy of absorptive hypercalciuria: a study performed on 18 lithiasic patients. J Urol. 1989; 142:1018-20.
66. Gleeson MJ, Thompson AS, Mehta S, Griffith D P. Effect of unprocessed wheat bran on calciuria and oxaluria in patients with urolithiasis. Urology. 1990; 35:231-4.
67. Sweeney DD, Tomaszewski JJ, Ricchiuti DD, Averch TD. Effect of carbohydrate-electrolyte sports beverages on urinary stone risk factors. J Urol. 2009; 182:992-7.
68. Zimmermann DJ, Hesse A, von Unruh GE. Influence of a high-oxalate diet on intestinal oxalate absorption. World J Urol. 2005; 23:324-9.
69. Butz M, Hoffmann H, Kohlbecker G. Dietary influence on serum and urinary oxalate in healthy subjects and oxalate stone formers. Urol Int. 1980; 35:309-1514.
70. Siener R, Ebert D, Nicolay C, Hesse A. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers. Kidney Int. 2003; 63:1037-43.
71. Massey LK, Sutton RA. Modification of dietary oxalate and calcium reduces urinary oxalate in hyperoxaluric patients with kidney stones. J Am Diet Assoc. 1993; 93:1305-7.
72. Kirac M, Küpeli B, Irkilata L, et al. Effects of dietary interventions on 24-hour urine parameters in patients with idiopathic recurrent calcium oxalate stones. Kaohsiung J Med Sci. 2013; 29:88-92.
73. Kirac M, Küpeli B, Irkilata L, et al. Effects of dietary interventions on 24-hour urine parameters in patients with idiopathic recurrent calcium oxalate stones. Kaohsiung J Med Sci. 2013; 29:88-92.
74. Laminski NA, Meyers AM, Kruger M, et al. Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors. Br J Urol. 1991; 68:454-8.
75. Griffith HM, O'Shea B, Maguire M, et al. A case-control study of dietary intake of renal stone patients. II. Urine biochemistry and stone analysis. Urol Res. 1986; 14:75-82.
76. Peña de la Vega L, Lieske JC, Milliner D, et al. Urinary oxalate excretion increases in home parenteral nutrition patients on a higher intravenous ascorbic acid dose. JPEN J Parenter Enteral Nutr. 2004; 28:435-8.
77. Massey LK, Liebman M, Kynast-Gales SA. Ascorbate increases human oxaluria and kidney stone risk. J Nutr. 2005; 135:1673-7.
78. Eisner BH, Sheth S, Dretler S P, et al. High dietary magnesium intake decreases hyperoxaluria in patients with nephrolithiasis. Urology. 2012; 80:780-3.
79. Trinchieri A, Ostini F, Nespoli R, et al. Hyperoxaluria in patients with idiopathic calcium nephrolithiasis. J Nephrol. 1998; 11 Suppl 1:70-2.
80. von Unruh GE, Voss S, Sauerbruch T, Hesse A. Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2]oxalate absorption test. J Urol. 2003; 169:687-90.
81. von Unruh GE, Voss S, Sauerbruch T, Hesse A. Dependence of oxalate absorption on the daily calcium intake. J Am Soc Nephrol. 2004; 15:1567-73.
82. Bataille P, Pruna A, Gregoire I, et al. Critical role of oxalate restriction in association with calcium restriction to decrease the probability of being a stone former: insufficient effect in idiopathic hyper-calciuria. Proc Eur Dial Transplant Assoc. 1983; 20:401-6.
83. Jaeger P, Portmann L, Jacquet A F, Burckhardt P. Influence of the calcium content of the diet on the incidence of mild hyperoxaluria in idiopathic renal stone formers. Am J Nephrol. 1985; 5:40-4.
84. Brown JM, Stratmann G, Cowley DM, et al. The variability and dietary dependence of urinary oxalate excretion in recurrent calcium stone formers. Ann Clin Biochem. 1987; 24:385-90.
85. Nakada T, Sasagawa I, Furuta H, et al. Effect of high-calcium diet on urinary oxalate excretion in urinary stone formers. Eur Urol. 1988; 15:264-70.
86. Penniston KL, Nakada SY. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation. Urology. 2009; 73:484-9.
87. Marangella M, Bianco O, Martini C, et al. Effect of animal and vegetable protein intake on oxalate excretion in idiopathic calcium stone disease. Br J Urol. 1989; 63:348-51.
88. Siener R, Hesse A. The effect of different diets on urine composition and the risk of calcium oxalate crystallisation in healthy subjects. Eur Urol. 2002; 42:289-96.
89. Noori N, Honarkar E, Goldfarb DS, et al. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets. Am J Kidney Dis. 2014; 63:456-63.
90. Meschi T, Maggiore U, Fiaccadori E, et al. The effect of fruits and vegetables on urinary stone risk factors. Kidney Int. 2004; 66:2402-10.
91. Nguyen Q V, Kälin A, Drouve U, Casez J P, Jaeger P. Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone formers. Kidney Int. 2001; 59:2273-81.
92. Giannini S, Nobile M, Sartori L, et al. Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr. 1999; 69:267-71.
93. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002; 346:77-84.
94. Nouvenne A, Meschi T, Guerra A, et al. Diet to reduce mild hyper-oxaluria in patients with idiopathic calcium oxalate stone formation: a pilot study. Urology. 2009; 73:725-30.
95. Gleeson MJ, Thompson AS, Mehta S, Griffith D P. Effect of unprocessed wheat bran on calciuria and oxaluria in patients with urolithiasis. Urology. 1990; 35:231-4.
96. Mitwalli A, Ayiomamitis A, Grass L, Oreopoulos DG. Control of hyperoxaluria with large doses of pyridoxine in patients with kidney stones. Int Urol Nephrol. 1988; 20:353-9.
97. Ortiz-Alvarado O, Miyaoka R, Kriedberg C, et al. Pyridoxine and dietary counseling for the management of idiopathic hyperoxaluria in stone-forming patients. Urology. 2011; 77:1054-8.
98. Goldfarb DS, Modersitzki F, Asplin JR. A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria. Clin J Am Soc Nephrol. 2007; 2:745-9.
99. Lieske JC, Tremaine WJ, De Simone C, et al. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation. Kidney Int. 2010; 78:1178-85.
100. Siener R, Bade DJ, Hesse A, Hoppe B. Dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria. J Transl Med. 2013; 12; 11:306.
101. Ferraz RR, Marques NC, Froeder L, et al. Effects of Lactobacillus casei and Bifidobacterium breve on urinary oxalate excretion in nephrolithiasis patients. Urol Res. 2009; 37:95-100.
102. Mahe JL, Cledes J, Bigot JC, et al. Results of dietary evaluation during calcium oxalate and calcium phosphate lithiasis. Nephrologie. 1993; 14:291-7.
103. Nomura K1, Ito H, Masai M, et al. Reduction of urinary stone recurrence by dietary counseling after SWL. J Endourol. 1995; 9:305-12.
104. Kocvara R, Plasgura P, Petrík A, et al. A prospective study of nonmedical prophylaxis after a first kidney stone. BJU Int. 1999; 84:393-8.
105. Siener R, Schade N, Nicolay C, et al. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J Urol. 2005; 173:1601-5.
106. Schwen ZR, Riley JM, Shilo Y, Averch TD. Dietary management of idiopathic hyperoxaluria and the influence of patient characteristics and compliance. Urology. 2013; 82:1220-5.
107. Oehlschläger S, Albrecht S, Hakenberg O W, et al. Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsy. Urology. 2003; 62:17-21.
108. Zuckerman JM, Assimos DG. Hypocitraturia: pathophysiology and medical management. Rev. Urol. 2009; 11:134-144.
109. Caudarella R, Vescini F, Buffa A, et al Citrate and mineral metabolism: kidney stones and bone disease Front Biosci. 2003; 1;8:s1084-106.
110. Ettinger B, Pak CY, Citron JT, et al. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997; 158:2069-2073.
111. Barcelo P, Wuhl O, Servitge E, et al. Randomised double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithia-sis. J Urol.1993; 150:1761-1764.
112. Domrongkitchaiporn S, Stitchantrakul W, Kochakarn W. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion. Am J Kidney Dis. 2006; 48:546-54.
113. Hess B, Michel R, Takkinen R, et al. Risk factors for low urinary citrate in calcium nephrolithiasis: low vegetable fibre intake and low urine volume to be added to the list. Nephrol Dial Transplant. 1994; 9:642-9.
114. Siener R, Schade N, Nicolay C, et al.The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J Urol. 2005; 173:1601-5.
115. Trinchieri A, Lizzano R, Marchesotti F, Zanetti G. Effect of potential renal acid load of foods on urinary citrate excretion in calcium renal stone formers. Urol Res. 2006; 34:1-7.
116. Trinchieri A, Maletta A, Lizzano R, Marchesotti F. Potential renal acid load and the risk of renal stone formation in a case-control study.Eur J Clin Nutr. 2013; 67:1077-80.
117. Meschi T, Maggiore U, Fiaccadori E, et al. The effect of fruits and vegetables on urinary stone risk factors. Kidney Int. 2004; 66:2402-10.
118. Haleblian GE, Leitao VA, Pierre SA, et al. Assessment of citrate concentrations in citrus fruit-based juices and beverages: implications for management of hypocitraturic nephrolithiasis. J. Endourol. 2008; 22:1359-1366.
119. Seltzer MA, Low RK, McDonald M, et al. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol. 1996; 156:907-909
120. Aras B, Kalfazade N, Tugcu V, et al. Can lemon juice be an alternative to potassium citrate in the treatment of urinary calcium stones in patients with hypocitraturia? A prospective randomized study. Urol Res. 2008; 36:313-7.
121. Kang DE, Sur RL, Haleblian GE, et al. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis. J Urol. 2007; 177:1358-1362
122. Koff SG, Paquette EL, Cullen J, et al. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation. Urology. 2007; 69:1013-1016.
123. Penniston KL, Steele, TH, Nakada SY. Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation. Urology. 2007; 70:856-860.
124. Odvina C V. Comparative value of orange juice versus lemonade in reducing stone-forming risk. Clin J Am Soc Nephrol. 2006; 1:1269-1274.
125. Wabner CL, Pak CY. Effect of orange juice consumption on urinary stone risk factors. J Urol. 1993; 149:1405-1408.
126. Goldfarb DS, Asplin JR. Effect of grapefruit juice on urinary lith-ogenicity. J Urol. 2001; 166:263-267.
127. Tosukhowong P, Yachantha C, Sasivongsbhakdi T, et al. Citraturic, alkalinizing and antioxidative effects of limeade-based regimen in nephrolithiasis patients. Urol Res. 2008; 36:149-155.
128. Gettman MT, Ogan K, Brinkley LJ, et al. Effect of cranberry juice consumption on urinary stone risk factors. J Urol. 2005; 174:590-4.
129. McHarg T, Rodgers A, Charlton K. Influence of cranberry juice on the urinary risk factors for calcium oxalate kidney stone formation. BJU Int. 2003; 92:765-768.
130. Kessler T, Jansen B, Hesse A. Effect of blackcurrant-, cranberry-and plum juice consumption on risk factors associated with kidney stone formation. Eur J Clin Nutr. 2002; 56:1020-1023.
131. Baia Lda C, Baxmann AC, Moreira SR, et al. Noncitrus alkaline fruit: a dietary alternative for the treatment of hypocitraturic stone formers. J Endourol. 2012; 26:1221-1226.
132. Goodman J W, Asplin JR, Goldfarb DS. Effect of two sports drinks on urinary lithogenicity. Urol Res. 2009; 37:41-46.
133. Passman CM, Holmes R P, Knight J, et al. Effect of soda consumption on urinary stone risk parameters. J Endourol. 2009; 23:347-350.
134. Van't Hoff WG. Aetiological factors in pediatric urolithiasis. Nephron Clin Pract 2004; 98:c45-c48.
135. Gearhart J P, Herzberg GZ, Jeffs RD. Childhood urolithiasis: experiences and advances. Pediatrics 1991; 87:445-450.
136. Diamond DA. Clinical patterns of paediatric urolithiasis. Brit J Urol. 1991; 68:195-198.
137. Milliner DS, Murphy ME. Urolithiasis in pediatric patients. Mayo Clin Proc. 1993; 68:241-248.
138. Coward RJM, Peters CJ, Duffy PG, et al. Epidemiology of paediatric renal stone disease in the UK. Arch Dis Child. 2003; 88:962-965.
139. Drach G W. Metabolic evaluation of pediatric patients with stones. Urol Clin N Am. 1995; 22:95-100.
140. DeFoor WR, Jackson E, Minevich E, et al. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate. Urology. 2010; 76:242-246.
141. Karabacak OR, Ipek B, Ozturk U, et al. Metabolic evaluation in stone disease metabolic differences between the pediatric and adult patients with stone disease. Urology. 2010; 76:238-241.
142. Alaya A, Acoy T, Nouri A, Najjar M F. Nutritional aspects of idio-pathic nephrolithiasis in Tunisian children. Arch Ital Urol Androl. 2011; 83:136-140.
143. Kovacevic L, Wolfe-Christensen C, Edwards L, et al. From hyper-calciuria to hypocitraturia-a shifting trend in pediatric urolithiasis? J Urol 2012; 188:1623-1627.
144. Tekin A, Tekgul S, Atsu N, et al. A study of the etiology of idio-pathic calcium urolithiasis in children: hypocitraturia in the most important risk factor. J Urol. 2000; 164:162-165.
145. Miller LA, Stapleton FB. Urinary volume in children with urolithi-asis. J Urol. 1989; 141:918-920.
146. Saez-Torres C, Grases F, Rodrigo D, et al. Risk factors for urinary stones in healthy schoolchildren with and without a family history of nephrolithiasis. Pediatr Nephrol. 2013; 28:639-645.
147. DeFoor W, Asplin J, Jackson E, et al. Urinary metabolic evaluation in normal and stone forming children. J Urol. 2006; 176:1793-1796.
148. Freycon M T, Frederich A, Durr F, et al. Taux sériques de 25 hydroxyvitamine D chez les nourrissons hospitalés. Rapport avec la calciurie. Pédiatrie. 1989; 44:419-423.
149. Misselwitz J, Hesse V, Markestad T. Nephrocalcinosis, hypercalci-uria and elevated serum levels of 1, 25-dihydroxyvitamin D in children. Acta Pediatr Scand. 1990; 79:637-643.
150. Veenhuizen L, Donckerwolcke RAMG. Role of 1, 25-dihydroxyvitamin D production in idiopathic hypercalciuria. Child Nephrol Urol. 1991; 11:69-73.
151. Neuhaus TJ, Belzer T, Blau N, et al. Urinary oxalate excretion in urolithiasis and nephrocalcinosis. Arch Dis Child. 2000; 82:322-326.
152. Sarica K, Eryildrim B, Yencilek F, Kuyumcuoglu U. Role of overweight status on stone-forming risk factors in children: a prospective study. Urology. 2009; 73:1003-1007.
153. Eisner BH, Eisenberg ML, Stoller ML. Influence of body mass index on quantitative 24-hour urine chemistry studies in children with nephrolithiasis. J Urol. 2009; 182:1142-1146.
154. Kieran K, Giel D W, Morris BJ, et al. Pediatric urolithiasis-Does body mass index influence stone presentation and treatment? J Urol. 2010; 184:1810-1815.
155. Martinez ME, Villa E, Vazquez Martul M, et al. Influence of calcium intake on calcitriol levels in idiopathic hypercalciuria in children. Nephron. 1993; 65:36-39.
156. Sellers EAC, Sharma A, Rodd C. Adaptation of Inuit children to a low-calcium diet. CMAJ 2003; 168:1141-1143.
157. Polito C, La Manna A, Maiello R, et al. Urinary sodium and potassium excretion in idiopathic hypercalciuria of children. Nephron. 2002; 91:7-12.
158. Osorio AV, Alon US. The relationship between urinary calcium, sodium and potassium excretion and the role of potassium in treating idiopathic hypercalciuria. Pediatrics 1997; 100:675-681.
159. Alon US, Berenbom A. Idiopathic hypercalciuria of childhood: 4-to 11-year outcome. Pediatr Nephrol. 2000; 14:1011-1015.
160. Alon US, Zimmerman H, Alon M. Evaluation and treatment of pediatric idiopathic urolithiasis-revisited. Pediatr Nephrol. 2004; 19:516-520.
161. Liern M, Bohorquez M, Vallejo G. Treatment of idiopathic hyper-calciuria and its impact on associated diseases. Arch Argent Pediatr. 2013; 111:110-114.
162. Tabel Y, Mir S. The long-term outcomes of idiopathic hypercalci-uria in children. J Pediatr Urol. 2006; 2:453-458.
163. Gurgoze MK, Sari M Y. Results of medical treatment and metabolic risk factors in children with urolithiasis. Pediatr Nephrol. 2011; 26:933-937.
164. Ross SS, Masko EM, Abern MR, et al. The effect of dietary sodium and fructose intake on urine and serum parameters of stone formation in a pediatric mouse model: a pilot study. J Urol. 2013; 190:1484-1489.
165. Grases F, Saez-Torres C, Rodriguez A, et al. Urinary phytate (Myo-inositol hexaphosphate) in healthy school children and risk of nephrolithiasis. J Ren Nutr. 2014; 24:219-223.
166. Lynch C, Kristjansdottir AG, Te Velde SJ, et al. Fruit and vegetable consumption in a sample of 11-year-old children in ten European countries-The PRO GREENS cross-sectional survey. Public Health Nutr. 2014; 15:1-9.
167. Kim SA, Moore LV, Galuska D, et al. Vital signs: fruit and vegetable intake among children-United States, 2003-2010. Morbid Mortal Wkl Rep. 2014; 63:671-676.
168. Tekin A, Tekgul S, Atsu N, et al. Oral potassium citrate treatment for idiopathic hypocitraturia in children with calcium nephrolithiasis. J Urol. 2002; 168:2572-2574.
169. Nguyen NU, Henriet M T, Dumoulin G, et al. Increase in calci-uria and oxaluria after a single chocolate bar load. Horm Metab Res. 1994; 26:383-386.
170. de Mendonça OGC, Martini LA, Baxmann AC, et al. Effects of an oxalate load on urinary oxalate excretion in calcium stone formers. J Ren Nutr. 2003; 13:39-46.
171. Rodgers A. Effect of cola consumption on urinary biochemical and physiochemical risk factors associated with calcium oxalate urolithiasis. Urol Res. 1999; 27:77-81.
172. Brinkley LJ, Gregory J, Pak CYC. A further study on oxalate bioavalaibility in foods. J Urol. 1990; 144:94-96.
173. Seligson FH, Krummel DA, Apgar JL. Patterns of chocolate consumption. Am J Clin Nutr. 1994; 60S:1060S-1064S.
174. Ogden CL, Kit BK, Carroll MD, Park S. Consumption of sugar drinks in the United States, 2005-2008. NCHS Data Brief. 2011; 7:1-8.
175. Duffey KJ, Huybrechts I, Mouratidou T, et al. Beverage consumption among European adolescents in the HELENA study. Eur J Clin Nutr. 2012; 66:244-252.
176. Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996; 155:839-843.
177. Dent CE, Senior B. Studies on the treatment of cystinuria. Br J Urol. 1955; 27:317-322.
178. Miyagi K, Nakada F, Ohshiro S. Effect of glutamine on cystine excretion in a patient with cystinuria. N Engl J Med. 1979; 301:196-199.
179. Jaeger P, Portmann L, Saunders A, et al. Anticystinuric effects of glutamine and of dietary sodium restriction. N Engl J Med. 1986; 315:1120-1123.
180. Norman R W, Manette WA. Dietary restriction of sodium as a means of reducing urinary cystine. J Urol. 1990; 143:1193-1195.
181. Saravakos P, Kokkinou V, Giannatos E. Cystinuria: current diagnosis and management. Urology. 2014; 83:693-699.
182. Torpy JM, Lynm C, Glass RM. JAMA patient page. Frailty in older adults. JAMA. 2006; 296:2280.
183. Purser JL, Kuchibhatla MN, Fillenbaum GG, et al. Identifying frailty in hospitalized older adults with significant coronary artery disease. J Am Geriatr Soc. 2006; 54:1674-1681.
184. Usui Y, Matsuzaki S, Matsushita K, et al. Urolithiasisin geriatric patients. J Exp Clin Med. 2003; 28:81.
185. Gentle DL, Stoller ML, Bruce JE, Leslie S W. Geriatric urolithia-sis. J Urol. 1997; 158:2221-4.
186. Asper R. Epidemiology and socioeconomic aspects of urolithais. Urol Res. 1984; 12:1.
187. Hiatt RA, Dales LG, Friedman GD, Hunkeler EM. Frequency of urolithiasis in prepaid medical care program. Amer. J. Epidemiol. 115:255-1982.
188. Moesch C, Charmes J P, Gaches F, et al. Crystalluria prevalence in the elderly. Eur J Med. 1993; 2:512.
189. Knoll T, Schubert AB, Fahlenkamp D, et al. Urolithiasis through the ages: data on more than 200, 000 urinary stone analyses.J Urol. 2011; 185:1304-11.
190. Krambeck AE1, Lieske JC, Li X, et al. Effect of age on the clinical presentation of incident symptomatic urolithiasis in the general population. J Urol. 2013; 189:158-64.
191. Stoller ML. Gout and stones or stones and gout? J. Urol. 1995; 154:1670.
192. Riese RJ, Sakhaee J. Uric acid nephrolithiasis: Dathogenesis and treatment. J Urol. 1992; 148:7657.
193. Yagisawa T, Hayashi T, Yoshida A, et al. Metabolic characteristics of the elderly with recurrent calcium oxalate stones. BJU Int. 1999; 83:924-8.
194. Freitas Junior CH, Mazzucchi E, Danilovic A, et al. Metabolic assessment of elderly men with urolithiasis. Clinics (Sao Paulo). 2012; 67:457-61.
195. Fardellone P, Sebert JL, Garabedian M, et al. Prevalence and biological consequences of vitamin D deficiency in elderly institutionalized subjects. Rev Rheum. 1995; 62:576.
196. Komar L, Nieves J, Cosman F, et al. Calcium homeostasis of an elderly population upon admission to a nursing home. J Amer Ger Soc. 1993; 41:1057.
197. Taylor EN, Fung TT, Curhan GC. DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol. 2009; 20:2253-9.
198. Ettinger B, Pak C Y, Citron JT, et al. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997; 158:2069-73.
199. Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006; 48:905-15.
200. Messa P, Marangella M, Paganin L, et al. Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones. Clin Sci (Lond). 1997; 93:257-63.
201. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011; 96:53-8.
202. Taylor EN, Curhan GC. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol 2007; m18: 2198-2204.
203. Sonnenblick M, Friedlander Y, Rosin AJ. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest. 1993; 103:601-6.